Calum MacRae

Scientific Advisor
Calum MacRae

Calum MacRae, MD, PhD, is Professor of Medicine at Harvard Medical School, Vice Chair for Innovation in the Department of Medicine at Brigham and Women’s Hospital (BWH), an Associate Member at the Broad Institute of Harvard and MIT and a Principal Faculty Member at the Harvard Stem Cell Institute.

He was previously Chief of Cardiovascular Medicine at BWH. He co-directs the Genomic Medicine Program at BWH, is a member of the Cardiovascular Clinical Genetics Center and is an investigator in the Harvard Undiagnosed Diseases Center.

Dr. MacRae is the Director of One Brave Idea, a program to transform translation, initially in atherosclerosis, that is funded jointly by the American Heart Association, Verily Life Sciences and AstraZeneca with support from Quest Diagnostics.

He is also the principal investigator of the Apple Heart & Movement study and directs an NIH-funded basic science group focused on the developmental basis of disease and phenotype-driven drug discovery.

Current Affiliation:
Harvard Medical School
Brigham and Women’s Hospital
Harvard Stem Cell Institute

Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
USA
© 2019-2024 - Dewpoint Therapeutics

Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science